SCHEMBL5811091

SCHEMBL5811091

O=C(NCc1ccc2c(c1)CCO2)N1CCC1OC(c1ccccc1Cl)c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
RYR2 Q92736 1/20 0.42
TSHR P16473 1/20 0.41
FAAH O00519 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HRH3 Q9Y5N1 3/20 0.40
MAPT P10636 1/20 0.40
CHRM5 P08912 5/20 0.39
CHRM1 P11229 5/20 0.39
CHRM2 P08172 2/20 0.39
CHRM4 P08173 2/20 0.39
CHRM3 P20309 2/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD2 P14416 1/20 0.39
KCNE1 P15382 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5811095 0.90 RAB9A (0.44) RAB9ANPC1POLBRYR2TSHR
SCHEMBL5811099 0.79 RAB9A (0.45) RAB9ANPC1POLBRYR2FAAH
SCHEMBL5814006 0.79 HRH3 (0.48) POLBTSHRMEN1KMT2AHRH3
SCHEMBL4085298 0.78 NPC1 (0.44) RAB9ANPC1POLBRYR2TSHR
SCHEMBL29574831 0.78 NPC1 (0.44) RAB9ANPC1POLBRYR2TSHR
SCHEMBL5816771 0.73 HPGD (0.48) TSHRMEN1KMT2AMAPTCASP3
SCHEMBL5821899 0.72 FABP3 (0.43) RAB9ANPC1POLBMEN1KMT2A
SCHEMBL10107719 0.70 ALDH2 (0.68) RAB9ANPC1POLBTSHRMEN1
SCHEMBL4085189 0.70 RYR2 (0.46) RAB9ANPC1POLBRYR2TSHR
SCHEMBL5814013 0.69 GLA (0.44) POLBTSHRMEN1KMT2AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620395-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2006-02-01 EP disclosed
WO-2004096763-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2004-11-11 WO disclosed